Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Intravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study

View through CrossRef
Pretreatment with antihistamines for the prevention of hypersensitivity infusion reactions is recommended for certain biologics and chemotherapies. Cetirizine is the first injectable second-generation antihistamine recently approved for acute urticaria. A randomized, exploratory phase 2 study evaluated intravenous (IV) cetirizine 10 mg versus IV diphenhydramine 50 mg as pretreatment in patients receiving an anti-CD20 agent or paclitaxel. In the overall population (N = 34) and an elderly subgroup (n = 21), IV cetirizine was as effective as IV diphenhydramine in preventing infusion reactions (primary outcome) and associated with less sedation at all time points, a shorter infusion center stay, and fewer treatment-related adverse events.
Title: Intravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study
Description:
Pretreatment with antihistamines for the prevention of hypersensitivity infusion reactions is recommended for certain biologics and chemotherapies.
Cetirizine is the first injectable second-generation antihistamine recently approved for acute urticaria.
A randomized, exploratory phase 2 study evaluated intravenous (IV) cetirizine 10 mg versus IV diphenhydramine 50 mg as pretreatment in patients receiving an anti-CD20 agent or paclitaxel.
In the overall population (N = 34) and an elderly subgroup (n = 21), IV cetirizine was as effective as IV diphenhydramine in preventing infusion reactions (primary outcome) and associated with less sedation at all time points, a shorter infusion center stay, and fewer treatment-related adverse events.

Related Results

Intravenous Cetirizine Premedication to Mitigate Infusion-Related Reactions
Intravenous Cetirizine Premedication to Mitigate Infusion-Related Reactions
Infusion-related reactions (IRRs) are a recognized concern for chemotherapy, biologic agents, and newer immunotherapies. Antihistamines are frequently recommended to prevent or man...
Modern approaches to infusion therapy in pediatrics and chemotherapy
Modern approaches to infusion therapy in pediatrics and chemotherapy
Background. Systems for intravenous administration of blood products and drugs are divided into the systems for transfusion (pore diameter – 114-200 μm) and systems for infusion (p...
Alteration of Serum Liver Enzymes Level Caused by Cetirizine Hydrochloride in Exercise Performers
Alteration of Serum Liver Enzymes Level Caused by Cetirizine Hydrochloride in Exercise Performers
Background: Players regularly use cetirizine HCL for the prevention and treatment of various symptoms of allergy while playing in unfamiliar environments.    Objective: This ...
Enhancement Drip Dose Infusion Accuracy Based on Optocoupler and Microcontroller Sensor
Enhancement Drip Dose Infusion Accuracy Based on Optocoupler and Microcontroller Sensor
Setting the speed of infusion drops in a manual manner is by adjusting the clamp on the infusion set, where the nurse must count the number of infusion drops in the chamber at the ...
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DIPHENHYDRAMINE AND NAPROXEN IN PHARMACEUTICAL DOSAGE FORMS
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DIPHENHYDRAMINE AND NAPROXEN IN PHARMACEUTICAL DOSAGE FORMS
The aim of the present work is to develop a new simple sensitive accurate and economical analytical method and validation for the Simultaneous estimation of Diphenhydramine and Nap...
A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels
BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known wh...

Back to Top